Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type |Pathology location|Pathology Description|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-1|1|218|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|eye|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-2|1|220|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-3|1|228|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-4|1|295|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-5|1|336|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-6|1|361|Other deterministic changes|Whole body|used for viral/bacteria screen|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-7|1|387|Other deterministic changes|Whole body|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-8|1|401|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|eye|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-9|1|477|Other deterministic changes|Whole body|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-10|1|480|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-11|1|485|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-12|1|487|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-13|1|492|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-14|1|492|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-15|1|497|Other deterministic changes|Whole body|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-16|1|501|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology 
|8-1-1-17|1|501|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-18|1|501|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-19|1|508|Neoplasia malignant|Lower respiratory system|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-20|1|508|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-21|1|508|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-22|1|525|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-23|1|525|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-24|1|534|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|eye|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-25|1|534|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-26|1|536|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-27|1|536|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-28|1|540|Other deterministic changes|Reproductive system|cystic kidney|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-29|1|541|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-30|1|546|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-31|1|547|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-32|1|550|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-33|1|557|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-34|1|564|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-35|1|564|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-36|1|571|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-37|1|596|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-38|1|596|Neoplasia malignant|Lower respiratory system|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-39|1|610|Other deterministic changes|Whole body|Autolysed|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-40|1|633|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-41|1|660|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-42|1|675|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastases liver|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-43|1|681|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-44|1|688|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-45|1|694|Other deterministic changes|Whole body|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-46|1|704|Other deterministic changes|Whole body|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-47|1|713|Other deterministic changes|Whole body|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-48|1|718|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-49|1|732|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-50|1|739|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-51|1|745|Other deterministic changes|Whole body|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-52|1|756|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-53|1|757|Other deterministic changes|Whole body|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-54|1|763|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-55|1|765|Other deterministic changes|Whole body|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-56|1|770|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-57|1|772|Neoplasia malignant|Bone among musculo-skeletal system diseases|fibia/tibia|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-58|1|776|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-59|1|791|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-60|1|795|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-61|1|798|Neoplasia malignant|Bone among musculo-skeletal system diseases|femur|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-62|1|807|Neoplasia malignant|Bone among musculo-skeletal system diseases,MA: 0000018 - skeletal system|lumbar vertebrae,MPATH: 242 - hemangiosarcoma|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-63|1|807|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-64|1|809|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|spleen kidney thymus,MPATH: 513 - Lymphoid neoplasms|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-65|1|835|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-66|1|835|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|seminal vesicle|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-67|1|843|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|pancreas metast. liver|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-68|1|844|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-69|1|847|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-70|1|853|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-71|1|882|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-72|1|885|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-73|1|898|Neoplasia malignant|Bone among musculo-skeletal system diseases,MA: 0000018 - skeletal system|knee,MPATH: 242 - hemangiosarcoma|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-74|1|899|Neoplasia malignant|Bloodvessels among cardiovascular system|kidney, Ln, metast. liver|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-75|1|907|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-76|1|919|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-77|1|926|Neoplasia benign|Lower respiratory system|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-78|1|936|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-79|1|951|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple, metastat. lung|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-80|1|956|Neoplasia benign|Bone among musculo-skeletal system diseases|fibia/tibia|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-81|1|957|Other deterministic changes|Whole body|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-82|1|961|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-83|1|963|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-84|1|970|Neoplasia malignant|Lower respiratory system|multiple|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-85|1|974|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-86|1|981|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-87|1|995|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-88|1|995|Neoplasia benign|Lower respiratory system|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-89|1|1008|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-90|1|1019|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|malign. metast. in liver|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-91|1|1037|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|eye|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-92|1|1037|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|skin abscess|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-93|1|1066|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-94|1|1073|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-95|1|1089|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-96|1|1093|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-97|1|1096|Neoplasia malignant|Lower respiratory system|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-98|1|1099|Other deterministic changes|Bone among musculo-skeletal system diseases|prolapsed iv disc lumbar verte|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-99|1|1172|Neoplasia benign|Upper digestive tract|n/a|
8-1-1|Pu-Bq 0,n/a|1| 84|none (controls)|0|becquerels per g animal|not applicable or not supplied| n/a|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-1-100|1|1177|Neoplasia benign|Lower respiratory system|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-1|2|417|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|Abscess - prostate|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-2|2|424|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-3|2|436|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-4|2|472|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-5|2|484|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-6|2|486|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-7|2|486|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-8|2|493|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-9|2|496|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-10|2|504|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-11|2|549|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-12|2|558|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-13|2|568|Neoplasia malignant|Bone among musculo-skeletal system diseases|jaw|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-14|2|576|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-15|2|578|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-16|2|585|Neoplasia malignant|Lower respiratory system|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-17|2|592|Neoplasia malignant|Lower respiratory system|multiple|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-18|2|596|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-19|2|601|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-20|2|611|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-21|2|623|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-22|2|633|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-23|2|644|Other deterministic changes|Whole body|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-24|2|644|Other deterministic changes|Whole body|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-25|2|660|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-26|2|664|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-27|2|686|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-28|2|693|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-29|2|695|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-30|2|714|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-31|2|729|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-32|2|731|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-33|2|736|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-34|2|755|Neoplasia malignant|Lower respiratory system|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-35|2|756|Other deterministic changes|Whole body|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-36|2|764|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-37|2|764|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple, metastat. lung|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-38|2|765|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-39|2|768|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-40|2|776|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-41|2|780|Hyperplastic changes|Hepato-pancreatic system,MA: 0000358 - liver|Liver - foci of "clear" hepato,MPATH: 484 - hyperplastic nodule|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-42|2|780|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-43|2|787|Neoplasia malignant|Bone among musculo-skeletal system diseases| lumbar vertebrae|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-44|2|793|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple, metastat. lung|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-45|2|798|Neoplasia malignant|Lower respiratory system|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-46|2|801|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-47|2|804|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastases lung diaph|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-48|2|805|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-49|2|808|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-50|2|813|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-51|2|813|Neoplasia malignant|Lower respiratory system|metastat. diaph|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-52|2|822|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-53|2|834|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-54|2|835|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. kidney|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-55|2|848|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastases liver|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-56|2|850|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-57|2|850|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-58|2|854|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metastat. lung|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-59|2|870|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|ribs A,B,C,MPATH: 513 - Lymphoid neoplasms|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-60|2|872|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-61|2|877|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-62|2|882|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-63|2|882|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-64|2|883|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-65|2|884|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-66|2|887|Neoplasia benign|Lower respiratory system|multiple|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-67|2|888|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-68|2|889|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-69|2|897|Neoplasia benign|Lower respiratory system|multiple|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-70|2|898|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-71|2|899|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|pancreas metastat. liver|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-72|2|911|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-73|2|928|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastases lung rib|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-74|2|930|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-75|2|932|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metast. lung|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-76|2|945|Neoplasia benign|Adrenal gland  among endocrine systems,MA: 0000119 - adrenal gland medulla|,MPATH: 377 - pheochromocytoma|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-77|2|945|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-78|2|946|Neoplasia malignant|Lower respiratory system|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-79|2|946|Neoplasia malignant|Liver among hepato-pancreatic system diseases|Metast. lung|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-80|2|951|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-81|2|954|Neoplasia malignant|Lower respiratory system|metastat. rib diaphragma|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-82|2|968|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-83|2|974|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-84|2|983|Neoplasia malignant|Lower respiratory system|multiple|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-85|2|988|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-86|2|998|Neoplasia benign|Lower respiratory system|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-87|2|1014|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metast. lung|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-88|2|1019|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-89|2|1042|Neoplasia unclassified|Nervous system and special sense organs,MA: 0000003 - organ system|malig. paraganglioma - prostat,MPATH: 366 - neuroendocrine tumor|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-90|2|1051|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-91|2|1058|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-92|2|1059|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|Squamous cell papilloma - tong,MPATH: 446 - squamous cell carcinoma|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-93|2|1072|Other deterministic changes|Reproductive system|kidney cyst|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-94|2|1087|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-95|2|1096|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-96|2|1114|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-97|2|1115|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-98|2|1118|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-99|2|1120|Neoplasia malignant|Lower respiratory system|multiple|
8-1-2|Pu-Bq 5,n/a|1| 84|Pu-239 citrate|5|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-2-100|2|1131|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-1|3|339|Other deterministic changes|Whole body|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-2|3|409|Other deterministic changes|Whole body|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-3|3|413|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-4|3|414|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-5|3|437|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-6|3|439|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-7|3|515|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-8|3|528|Other deterministic changes|Whole body|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-9|3|545|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-10|3|650|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-11|3|652|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metast. lung|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-12|3|652|Neoplasia unclassified|Peripheral nerves  among nervous system|plevis|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-13|3|652|Other deterministic changes|Whole body|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-14|3|657|Neoplasia malignant|Lower respiratory system|multiple|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-15|3|661|Neoplasia malignant|Bone among musculo-skeletal system diseases|metastat. spleen|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-16|3|690|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-17|3|713|Neoplasia malignant|Bone among musculo-skeletal system diseases|metastat. lung|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-18|3|717|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-19|3|722|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-20|3|737|Other deterministic changes|Whole body|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-21|3|738|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|pancreas|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-22|3|751|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-23|3|758|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-24|3|759|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-25|3|764|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-26|3|768|Neoplasia malignant|Lower respiratory system|multiple|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-27|3|775|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-28|3|815|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-29|3|822|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-30|3|823|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-31|3|827|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat.  lung|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-32|3|830|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-33|3|830|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-34|3|830|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-35|3|836|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung lumbar vertebra|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-36|3|848|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-37|3|855|Neoplasia malignant|Bone among musculo-skeletal system diseases|thoracic vertebrae|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-38|3|860|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-39|3|862|Neoplasia malignant|Bone among musculo-skeletal system diseases|lumbar vertebrae|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-40|3|863|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|kidney,MPATH: 513 - Lymphoid neoplasms|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-41|3|864|Neoplasia malignant|Bone among musculo-skeletal system diseases|femur metastat. lung|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-42|3|864|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-43|3|866|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-44|3|868|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metastat. lung|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-45|3|884|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-46|3|895|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-47|3|902|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-48|3|909|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-49|3|910|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|spleen liver kidney lymph node,MPATH: 513 - Lymphoid neoplasms|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-50|3|927|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|spleen pancreas diaphragm,MPATH: 513 - Lymphoid neoplasms|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-51|3|928|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-52|3|935|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-53|3|962|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-54|3|1010|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-55|3|1018|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-56|3|1021|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-57|3|1025|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metast. kidney liver|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-58|3|1035|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-59|3|1042|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-3|Pu-Bq 15,n/a|1| 84|Pu-239 citrate|15|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-3-60|3|1109|Neoplasia malignant|Bone among musculo-skeletal system diseases|thoracic vertebrae|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-1|4|102|Other deterministic changes|Whole body|Died After Injection|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-2|4|104|Other deterministic changes|Whole body|Died After Injection|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-3|4|245|Other deterministic changes|Whole body|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-4|4|270|Other deterministic changes|Reproductive system|kidney cysts|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-5|4|294|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-6|4|294|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|eye|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-7|4|360|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|spleen,MPATH: 513 - Lymphoid neoplasms|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-8|4|405|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-9|4|443|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-10|4|451|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-11|4|464|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-12|4|464|Neoplasia malignant|Bone among musculo-skeletal system diseases|lumbar vertebrae|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-13|4|477|Neoplasia benign|Bloodvessels among cardiovascular system|femur|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-14|4|483|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-15|4|492|Neoplasia benign|Lower respiratory system|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-16|4|492|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-17|4|499|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-18|4|500|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-19|4|512|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-20|4|519|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-21|4|527|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-22|4|536|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-23|4|553|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-24|4|559|Neoplasia malignant|Bone among musculo-skeletal system diseases|femur|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-25|4|576|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-26|4|581|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-27|4|585|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|Meningeal sarcoma - brain,MPATH: 551 - sarcoma|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-28|4|595|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-29|4|608|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-30|4|617|Neoplasia malignant|Lower respiratory system|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-31|4|618|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|pancreas metastat. liver|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-32|4|619|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-33|4|625|Neoplasia benign|Pancreas among hepato-pancreatic system diseases|pancreas|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-34|4|625|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-35|4|630|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-36|4|632|Neoplasia malignant|Bone among musculo-skeletal system diseases,MA: 0000018 - skeletal system|knee,MPATH: 242 - hemangiosarcoma|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-37|4|636|Hyperplastic changes|Hepato-pancreatic system,MA: 0000354 - bile duct|,MPATH: 134 - hyperplasia|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-38|4|641|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-39|4|644|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-40|4|644|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-41|4|656|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-42|4|659|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-43|4|660|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-44|4|667|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-45|4|673|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-46|4|682|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-47|4|682|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-48|4|686|Neoplasia malignant|Lower respiratory system|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-49|4|687|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-50|4|689|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-51|4|689|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-52|4|699|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-53|4|700|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-54|4|710|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-55|4|714|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-56|4|714|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-57|4|716|Neoplasia benign|Liver among hepato-pancreatic system diseases|mutiple|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-58|4|721|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-59|4|723|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-60|4|725|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-61|4|731|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|spleen,MPATH: 513 - Lymphoid neoplasms|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-62|4|735|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-63|4|735|Other deterministic changes|Whole body|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-64|4|738|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-65|4|740|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-66|4|742|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-67|4|744|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-68|4|746|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-69|4|749|Neoplasia malignant|Bone among musculo-skeletal system diseases|femur|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-70|4|750|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metastat. lung|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-71|4|753|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-72|4|756|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-73|4|759|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|Atrial thrombus|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-74|4|759|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-75|4|759|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-76|4|763|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-77|4|773|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-78|4|773|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-79|4|778|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-80|4|780|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-81|4|785|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-82|4|786|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-83|4|797|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-84|4|798|Neoplasia malignant|Bone among musculo-skeletal system diseases|cervical vertebrae|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-85|4|798|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-86|4|799|Neoplasia malignant|Bone among musculo-skeletal system diseases|lumbar vertebrae|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-87|4|801|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-88|4|802|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-89|4|808|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-90|4|811|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-91|4|813|Neoplasia malignant|Bone among musculo-skeletal system diseases|femur|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-92|4|814|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-93|4|815|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-94|4|818|Neoplasia malignant|Bone among musculo-skeletal system diseases|femur|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-95|4|819|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-96|4|820|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-97|4|824|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-98|4|828|Neoplasia malignant|Bone among musculo-skeletal system diseases|caudal vertebrae|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-99|4|829|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-100|4|833|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-101|4|841|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metastat. lung|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-102|4|841|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-103|4|842|Neoplasia malignant|Lower respiratory system|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-104|4|842|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| bone, spleen,MPATH: 513 - Lymphoid neoplasms|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-105|4|849|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-106|4|861|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-107|4|869|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|GI tract spleen liver lung,MPATH: 513 - Lymphoid neoplasms|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-108|4|878|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-109|4|883|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-110|4|886|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-111|4|889|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastat. kidney lung tib/fib|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-112|4|891|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-113|4|894|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-114|4|895|Neoplasia malignant|Bone among musculo-skeletal system diseases|caudal vertebrae|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-115|4|916|Other deterministic changes|Whole body|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-116|4|922|Other deterministic changes|Whole body|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-117|4|924|Neoplasia malignant|Bone among musculo-skeletal system diseases|skull|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-118|4|931|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-119|4|942|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-120|4|952|Neoplasia malignant|Bone among musculo-skeletal system diseases|lumbar vertebrae paralys. legs|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-121|4|953|Neoplasia malignant|Bone among musculo-skeletal system diseases|leg|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-122|4|962|Neoplasia malignant|Bone among musculo-skeletal system diseases|lumbar vertebrae|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-123|4|963|Neoplasia malignant|Bone among musculo-skeletal system diseases| caudal vertebrae|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-124|4|970|Neoplasia malignant|Bone among musculo-skeletal system diseases,MA: 0000018 - skeletal system|Haemangiosarcoma - leg,MPATH: 242 - hemangiosarcoma|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-125|4|973|Neoplasia malignant|Bone among musculo-skeletal system diseases| thoracic vertebrae|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-126|4|987|Neoplasia malignant|Bone among musculo-skeletal system diseases|elbow|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-127|4|1037|Neoplasia malignant|Bone among musculo-skeletal system diseases|femur  metastat. liver|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-128|4|1072|Neoplasia benign|Lower respiratory system|n/a|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-129|4|1087|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung kidney|
8-1-4|Pu-Bq 25,n/a|1| 84|Pu-239 citrate|25|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|130 (130 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-4-130|4|1170|Neoplasia malignant|Bone among musculo-skeletal system diseases|leg|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-1|5|93|Other deterministic changes|Whole body|Died After Injection|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-2|5|96|Other deterministic changes|Whole body|Died After Injection|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-3|5|233|Other deterministic changes|Whole body|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-4|5|274|Other deterministic changes|Whole body|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-5|5|348|Other deterministic changes|Whole body|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-6|5|358|Other deterministic changes|Whole body|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-7|5|414|Neoplasia malignant|Bloodvessels among cardiovascular system|heart + lymph node|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-8|5|417|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|pancreas|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-9|5|431|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-10|5|441|Neoplasia malignant|Lower respiratory system|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-11|5|443|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-12|5|464|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metast. lung|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-13|5|464|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-14|5|469|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-15|5|469|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-16|5|471|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-17|5|471|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-18|5|472|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-19|5|477|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-20|5|479|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-21|5|490|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-22|5|543|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-23|5|554|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-24|5|564|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|eye|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-25|5|627|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-26|5|652|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|spleen liver kidneys,MPATH: 513 - Lymphoid neoplasms|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-27|5|696|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|spleen liver lung kidney git,MPATH: 513 - Lymphoid neoplasms|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-28|5|696|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-29|5|704|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|spleen kidney lymph node,MPATH: 513 - Lymphoid neoplasms|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-30|5|707|Neoplasia unclassified|Nervous system and special sense organs,MA: 0000003 - organ system|metastases liver,MPATH: 366 - neuroendocrine tumor|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-31|5|731|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-32|5|744|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-33|5|750|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-34|5|750|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-35|5|766|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastases lung|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-36|5|768|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-37|5|774|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-38|5|778|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-39|5|781|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-40|5|788|Neoplasia malignant|Lower respiratory system|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-41|5|788|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-42|5|790|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-43|5|791|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-44|5|801|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-45|5|807|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-46|5|813|Neoplasia malignant|Lower respiratory system|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-47|5|814|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-48|5|820|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastat. liver|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-49|5|835|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastat. liver lung|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-50|5|840|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-51|5|842|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-52|5|850|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-53|5|856|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-54|5|859|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-55|5|862|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-56|5|865|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-57|5|869|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-58|5|872|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-59|5|879|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-60|5|879|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-61|5|880|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-62|5|884|Neoplasia unclassified|Peripheral nerves  among nervous system|Malignant schwannoma - lumbar |
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-63|5|885|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|spleen liver sternum,MPATH: 513 - Lymphoid neoplasms|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-64|5|886|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-65|5|893|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|spleen lymph node GIT,MPATH: 513 - Lymphoid neoplasms|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-66|5|895|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metast. lung|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-67|5|896|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-68|5|896|Other deterministic changes|Whole body|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-69|5|901|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-70|5|913|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-71|5|923|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-72|5|923|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-73|5|925|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-74|5|925|Neoplasia malignant|Lower respiratory system|metastat. rib|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-75|5|926|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-76|5|927|Neoplasia malignant|Lower respiratory system|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-77|5|939|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-78|5|953|Neoplasia malignant|Lower respiratory system|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-79|5|962|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastat. liver, lung|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-80|5|967|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-81|5|967|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-82|5|967|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-83|5|969|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-84|5|973|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-85|5|981|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-86|5|981|Neoplasia malignant|Lower respiratory system|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-87|5|985|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-88|5|1005|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|spleen lumb vert sternum LN,MPATH: 513 - Lymphoid neoplasms|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-89|5|1008|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-90|5|1018|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-91|5|1030|Neoplasia malignant|Lower respiratory system|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-92|5|1069|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-93|5|1069|Neoplasia malignant|Lower respiratory system|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-94|5|1081|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-95|5|1103|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-96|5|1103|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-97|5|1106|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-98|5|1109|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|spleen,MPATH: 513 - Lymphoid neoplasms|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-99|5|1109|Neoplasia malignant|Reproductive system,MA: 0000404 - prostate gland|,MPATH: 268 - adenocarcinoma|
8-1-5|Am-Bq 5.8,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-5-100|5|1113|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-1|6|92|Other deterministic changes|Whole body|Died After Injection|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-2|6|97|Other deterministic changes|Whole body|Died After Injection|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-3|6|109|Other deterministic changes|Whole body|Died After Injection|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-4|6|312|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-5|6|345|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|Meningeal sarcoma  Mestast. lu,MPATH: 551 - sarcoma|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-6|6|350|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-7|6|354|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-8|6|373|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-9|6|392|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-10|6|419|Other deterministic changes|Whole body|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-11|6|465|Other deterministic changes|Whole body|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-12|6|472|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-13|6|483|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-14|6|504|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|spleen lumb vert sternum,MPATH: 513 - Lymphoid neoplasms|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-15|6|512|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-16|6|514|Other deterministic changes|Whole body|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-17|6|521|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-18|6|522|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-19|6|526|Inflammation and/or fibrotic diseases|Cardiovascular system,MA: 0000076 - heart endocardium|heart valve,MPATH: 212 - inflammation|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-20|6|527|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-21|6|536|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|Squamous cell carcinoma - ?pre,MPATH: 446 - squamous cell carcinoma|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-22|6|538|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-23|6|547|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-24|6|554|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-25|6|561|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-26|6|564|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-27|6|567|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-28|6|579|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-29|6|585|Neoplasia malignant|Spleen and thymus  among haematolymphatic system|thymoma malignant metast. lung|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-30|6|598|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-31|6|600|Neoplasia malignant|Lower respiratory system|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-32|6|613|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-33|6|617|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-34|6|618|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|liver sternum,MPATH: 513 - Lymphoid neoplasms|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-35|6|632|Neoplasia malignant|Bone among musculo-skeletal system diseases,MA: 0000018 - skeletal system|sacral vertebrae femurs,MPATH: 242 - hemangiosarcoma|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-36|6|640|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-37|6|649|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-38|6|649|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-39|6|655|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-40|6|662|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-41|6|665|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-42|6|666|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-43|6|667|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metast. liver lung|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-44|6|669|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-45|6|669|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-46|6|675|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metastat. lung|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-47|6|675|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-48|6|681|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-49|6|686|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-50|6|686|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-51|6|687|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-52|6|697|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|spleen GIT,MPATH: 513 - Lymphoid neoplasms|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-53|6|701|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-54|6|707|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-55|6|708|Neoplasia malignant|Bone among musculo-skeletal system diseases,MA: 0000018 - skeletal system|lumbar vertebrae,MPATH: 242 - hemangiosarcoma|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-56|6|709|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-57|6|709|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|spleen lung kidney GIT LNs,MPATH: 513 - Lymphoid neoplasms|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-58|6|715|Neoplasia malignant|Lower respiratory system|multiple metast. rib thor vert|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-59|6|717|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-60|6|723|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-61|6|724|Neoplasia malignant|Lower respiratory system|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-62|6|725|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-63|6|728|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|fibrosarcoma skin,MPATH: 551 - sarcoma|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-64|6|733|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-65|6|739|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-66|6|744|Neoplasia malignant|Lower respiratory system|?metastat rib.|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-67|6|751|Other deterministic changes|Whole body|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-68|6|751|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-69|6|753|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metastat. lung|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-70|6|754|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-71|6|754|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-72|6|756|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metastat.lung|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-73|6|758|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-74|6|764|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-75|6|767|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-76|6|770|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-77|6|771|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-78|6|772|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-79|6|773|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metastat. lung|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-80|6|775|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-81|6|776|Neoplasia malignant|Bone among musculo-skeletal system diseases|jaw|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-82|6|778|Other deterministic changes|Whole body|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-83|6|778|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metastat. lung|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-84|6|779|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-85|6|787|Neoplasia malignant|Reproductive system,MA: 0000404 - prostate gland|,MPATH: 268 - adenocarcinoma|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-86|6|787|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-87|6|789|Other deterministic changes|Whole body|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-88|6|789|Neoplasia malignant|Lower respiratory system|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-89|6|796|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-90|6|796|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-91|6|797|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-92|6|798|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-93|6|799|Neoplasia malignant|Bone among musculo-skeletal system diseases,MA: 0000018 - skeletal system|femur,MPATH: 242 - hemangiosarcoma|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-94|6|800|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-95|6|800|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-96|6|807|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-97|6|810|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-98|6|814|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-99|6|817|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-100|6|827|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|GIT LN,MPATH: 513 - Lymphoid neoplasms|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-101|6|830|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-102|6|837|Neoplasia malignant|Lower respiratory system|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-103|6|841|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-104|6|844|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-105|6|845|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-106|6|847|Neoplasia malignant|Lower respiratory system|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-107|6|852|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-108|6|857|Neoplasia malignant|Lower respiratory system|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-109|6|860|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-110|6|866|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metastat. lung|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-111|6|866|Neoplasia malignant|Liver among hepato-pancreatic system diseases|mutiple metastat. lumb. vert.,|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-112|6|869|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metast. lung|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-113|6|869|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastat. liver|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-114|6|869|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-115|6|886|Neoplasia malignant|Lower respiratory system|metastat. LN, diaphragm sternu|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-116|6|888|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-117|6|898|Neoplasia malignant|Bone among musculo-skeletal system diseases|thoracic vertebrae|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-118|6|901|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-119|6|901|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-120|6|906|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-121|6|922|Neoplasia malignant|Spleen and thymus  among haematolymphatic system|Malignant thymoma - lung?364|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-122|6|926|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung sternum|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-123|6|932|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metastat. lung|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-124|6|935|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-125|6|943|Neoplasia malignant|Lower respiratory system|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-126|6|946|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-127|6|951|Other deterministic changes|Whole body|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-128|6|957|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-129|6|957|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-130|6|957|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-131|6|961|Neoplasia benign|Upper digestive tract|Odontoma - jaw|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-132|6|967|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metast. lung|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-133|6|969|Neoplasia malignant|Bone among musculo-skeletal system diseases|lunbar vertebrae|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-134|6|987|Neoplasia malignant|Lower respiratory system|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-135|6|988|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|spleen GIT,MPATH: 513 - Lymphoid neoplasms|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-136|6|993|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-137|6|996|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-138|6|999|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metast. liver heart|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-139|6|1002|Neoplasia malignant|Bloodvessels among cardiovascular system|liver spleen|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-140|6|1012|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-141|6|1014|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-142|6|1014|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-143|6|1023|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-144|6|1032|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|GIT LN,MPATH: 513 - Lymphoid neoplasms|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-145|6|1040|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-146|6|1052|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-147|6|1062|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-148|6|1073|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 242 - hemangiosarcoma|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-149|6|1075|Neoplasia benign|Lower respiratory system|multiple|
8-1-6|Am-Bq 17.2,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|150 (150 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-6-150|6|1086|Neoplasia malignant|Bone among musculo-skeletal system diseases|lumbar vertebrae|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-1|7|95|Other deterministic changes|Whole body|died after injection|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-2|7|217|Other deterministic changes|Whole body|n/a|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-3|7|388|Other deterministic changes|Whole body|n/a|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-4|7|429|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-5|7|534|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-6|7|547|Neoplasia malignant|Bone among musculo-skeletal system diseases|lumbar vertebrae|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-7|7|591|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-8|7|598|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-9|7|611|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-10|7|613|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-11|7|616|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-12|7|632|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-13|7|642|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metastat.lung|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-14|7|675|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-15|7|675|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-16|7|683|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-17|7|692|Neoplasia malignant|Lower respiratory system|multiple|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-18|7|733|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-19|7|738|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-20|7|751|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-21|7|756|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-22|7|756|Neoplasia malignant|Liver among hepato-pancreatic system diseases|mulitple|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-23|7|759|Neoplasia malignant|Bone among musculo-skeletal system diseases|leg|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-24|7|773|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-25|7|779|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metast. lung|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-26|7|811|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-27|7|821|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-28|7|821|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-29|7|834|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metast. lung|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-30|7|843|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metastat. lung|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-31|7|856|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-32|7|859|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-33|7|869|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-34|7|876|Neoplasia malignant|Bone among musculo-skeletal system diseases|lumbar vertebrae|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-35|7|883|Neoplasia malignant|Lower respiratory system|multiple metastat. thymus sple|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-36|7|885|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-37|7|898|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-38|7|951|Neoplasia malignant|Bone among musculo-skeletal system diseases|lumbar vertebrae|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-39|7|974|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-40|7|974|Neoplasia malignant|Bone among musculo-skeletal system diseases|jaw|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-41|7|977|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metastat. lung|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-42|7|1009|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-43|7|1010|Neoplasia malignant|Bone among musculo-skeletal system diseases|thoracic vertebrae|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-44|7|1011|Neoplasia malignant|Bone among musculo-skeletal system diseases|caudal vertebrae|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-45|7|1032|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-46|7|1032|Neoplasia malignant|Bone among musculo-skeletal system diseases|pelvis|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-47|7|1054|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-48|7|1102|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-49|7|1107|Neoplasia malignant|Bone among musculo-skeletal system diseases|thoracic vertebrae|
8-1-7|Am-Bq 28.9,n/a|1| 84|Am-241 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-7-50|7|1108|Neoplasia malignant|Bone among musculo-skeletal system diseases|lumbar vertebrae|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-1|8|100|Other deterministic changes|Whole body|Died After Injection|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-2|8|431|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-3|8|455|Other deterministic changes|Whole body|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-4|8|502|Other deterministic changes|Whole body|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-5|8|510|Other deterministic changes|Whole body|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-6|8|516|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-7|8|522|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-8|8|547|Neoplasia malignant|Bone among musculo-skeletal system diseases|arm, metastat. lung|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-9|8|550|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-10|8|569|Other deterministic changes|Whole body|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-11|8|576|Other deterministic changes|Whole body|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-12|8|593|Neoplasia malignant|Lower respiratory system|Metastases ?bronchiolo-alveola|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-13|8|597|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-14|8|611|Neoplasia malignant|Bone among musculo-skeletal system diseases,MA: 0000018 - skeletal system| lumbar vertebrae,MPATH: 242 - hemangiosarcoma|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-15|8|619|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-16|8|634|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-17|8|638|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-18|8|640|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-19|8|645|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-20|8|648|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-21|8|661|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-22|8|662|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-23|8|667|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-24|8|667|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-25|8|676|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-26|8|687|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-27|8|688|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-28|8|690|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-29|8|690|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-30|8|696|Other deterministic changes|Whole body|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-31|8|700|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-32|8|708|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-33|8|709|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-34|8|710|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-35|8|713|Other deterministic changes|Whole body|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-36|8|718|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-37|8|719|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-38|8|721|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-39|8|722|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-40|8|723|Other deterministic changes|Whole body|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-41|8|728|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-42|8|730|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metast. lung|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-43|8|739|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-44|8|742|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metastat. lung sternu|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-45|8|744|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-46|8|744|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-47|8|757|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-48|8|758|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-49|8|759|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-50|8|766|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-51|8|781|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-52|8|786|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-53|8|791|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-54|8|795|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-55|8|795|Neoplasia malignant|Lower respiratory system|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-56|8|800|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-57|8|808|Neoplasia malignant|Lower respiratory system|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-58|8|813|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-59|8|815|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 242 - hemangiosarcoma|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-60|8|816|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metastat. lung|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-61|8|823|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-62|8|823|Neoplasia malignant|Reproductive system,MA: 0000404 - prostate gland|,MPATH: 268 - adenocarcinoma|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-63|8|826|Other deterministic changes|Whole body|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-64|8|842|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-65|8|844|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-66|8|848|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|Metastases neuroendocrine ca -|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-67|8|855|Neoplasia benign|Lower respiratory system|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-68|8|856|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-69|8|875|Neoplasia malignant|Lower respiratory system|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-70|8|876|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-71|8|879|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-72|8|896|Other deterministic changes|Whole body|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-73|8|900|Neoplasia malignant|Lower respiratory system|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-74|8|907|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-75|8|912|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-76|8|914|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-77|8|936|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-78|8|939|Neoplasia malignant|Lower respiratory system|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-79|8|940|Neoplasia malignant|Lower respiratory system|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-80|8|942|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-81|8|942|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-82|8|953|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-83|8|954|Neoplasia unclassified|Nervous system and special sense organs,MA: 0000003 - organ system|,MPATH: 366 - neuroendocrine tumor|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-84|8|956|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|spleen kidney liver lung LN,MPATH: 513 - Lymphoid neoplasms|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-85|8|970|Neoplasia benign|Bone among musculo-skeletal system diseases|jaw|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-86|8|973|Neoplasia malignant|Reproductive system,MA: 0000410 - seminal vesicle|,MPATH: 268 - adenocarcinoma|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-87|8|975|Neoplasia malignant|Reproductive system,MA: 0000410 - seminal vesicle|,MPATH: 268 - adenocarcinoma|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-88|8|980|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-89|8|991|Neoplasia malignant|Lower respiratory system|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-90|8|1001|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-91|8|1024|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-92|8|1031|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-93|8|1037|Neoplasia malignant|Lower respiratory system|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-94|8|1044|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-95|8|1051|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|spleen lung liver kidney lumb ,MPATH: 513 - Lymphoid neoplasms|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-96|8|1064|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-97|8|1065|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metastat. lung|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-98|8|1075|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|spleen lumb vert femur,MPATH: 513 - Lymphoid neoplasms|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-99|8|1108|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-8|U-Bq  39.5,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 104 mGy multiple 9 ip injections|100 (100 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-8-100|8|1142|Neoplasia malignant|Bone among musculo-skeletal system diseases|sternum|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-1|9|301|Other deterministic changes|Whole body|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-2|9|311|Other deterministic changes|Whole body|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-3|9|316|Other deterministic changes|Whole body|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-4|9|463|Other deterministic changes|Whole body|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-5|9|515|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-6|9|525|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-7|9|546|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-8|9|547|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-9|9|548|Neoplasia benign|Lower respiratory system|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-10|9|581|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-11|9|597|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-12|9|599|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metastat. lung|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-13|9|648|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-14|9|648|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-15|9|675|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-16|9|675|Neoplasia malignant|Lower respiratory system|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-17|9|686|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-18|9|688|Neoplasia malignant|Bloodvessels among cardiovascular system|spleen liver|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-19|9|697|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-20|9|705|Other deterministic changes|Whole body|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-21|9|707|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-22|9|707|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-23|9|718|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-24|9|722|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-25|9|725|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-26|9|732|Neoplasia malignant|Lower respiratory system|metastat. rib A B C sternum|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-27|9|739|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-28|9|760|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-29|9|762|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-30|9|775|Other deterministic changes|Whole body|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-31|9|777|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-32|9|784|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-33|9|790|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-34|9|802|Neoplasia systemic|Haematolymphatic system|lumbar vertebrae sternum|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-35|9|816|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-36|9|819|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-37|9|844|Other deterministic changes|Whole body|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-38|9|848|Other deterministic changes|Whole body|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-39|9|856|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-40|9|869|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastat. liver sternum|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-41|9|872|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-42|9|894|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metastat. lung|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-43|9|907|Neoplasia systemic|Haematolymphatic system|lumbar vertebrae|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-44|9|910|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-45|9|910|Other deterministic changes|Whole body|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-46|9|914|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-47|9|937|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-48|9|941|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-49|9|957|Neoplasia malignant|Bone among musculo-skeletal system diseases|lumbar vertebrae|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-50|9|979|Other deterministic changes|Whole body|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-51|9|1005|Neoplasia malignant|Lower respiratory system|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-52|9|1012|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-53|9|1029|Neoplasia malignant|Lower respiratory system|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-54|9|1030|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metast. liver|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-55|9|1036|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-56|9|1082|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-57|9|1100|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-58|9|1102|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-59|9|1131|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-9|U-Bq 117.6,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 310 mGy multiple 9 ip injections|60 (60 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-9-60|9|1132|Neoplasia malignant|Lower respiratory system|multiple|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-1|10|318|Other deterministic changes|Whole body|n/a|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-2|10|396|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-3|10|502|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-4|10|512|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-5|10|520|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-6|10|527|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-7|10|533|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-8|10|563|Neoplasia malignant|Endocrine system|metastat. lung|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-9|10|577|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-10|10|592|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-11|10|593|Other deterministic changes|Whole body|n/a|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-12|10|599|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-13|10|612|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-14|10|617|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-15|10|633|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-16|10|639|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metastat. lung|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-17|10|646|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-18|10|659|Neoplasia malignant|Bone among musculo-skeletal system diseases|lumbar vertebrae|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-19|10|667|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastat. liver|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-20|10|679|Neoplasia malignant|Spleen and thymus  among haematolymphatic system|malignant metast. GI, lung|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-21|10|688|Neoplasia systemic|Haematolymphatic system|n/a|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-22|10|728|Neoplasia malignant|Reproductive system,MA: 0000404 - prostate gland|,MPATH: 268 - adenocarcinoma|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-23|10|736|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-24|10|739|Other deterministic changes|Whole body|n/a|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-25|10|743|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-26|10|760|Other deterministic changes|Whole body|n/a|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-27|10|764|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-28|10|771|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000565 - mesothelium|heart metastat. kidney, saliv.,MPATH: 365 - mesothelioma|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-29|10|786|Neoplasia malignant|Integumentary system|n/a|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-30|10|796|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-31|10|804|Neoplasia malignant|Bloodvessels among cardiovascular system|liver|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-32|10|806|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-33|10|806|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-34|10|813|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-35|10|820|Neoplasia malignant|Lower respiratory system|n/a|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-36|10|833|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastat. lung|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-37|10|848|Neoplasia malignant|Bloodvessels among cardiovascular system|kidney|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-38|10|851|Neoplasia malignant|Reproductive system,MA: 0000404 - prostate gland|,MPATH: 268 - adenocarcinoma|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-39|10|862|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-40|10|866|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|spleen lung liver LN thymus,MPATH: 513 - Lymphoid neoplasms|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-41|10|891|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-42|10|914|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|spleen kidney liver lung,MPATH: 513 - Lymphoid neoplasms|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-43|10|935|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-44|10|938|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|multiple,MPATH: 549 - carcinoma|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-45|10|938|Neoplasia malignant|Lower respiratory system|multiple|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-46|10|975|Neoplasia malignant|Integumentary system|amelanotic|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-47|10|975|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|spleen kidney lung adrenal,MPATH: 513 - Lymphoid neoplasms|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-48|10|1004|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-49|10|1053|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
8-1-10|U-Bq 197.3,n/a|1| 84|U-233 citrate|197.3|becquerels per g animal|Injection, intraperitoneal| 520 mGy multiple 9 ip injections|50 (50 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study macro/microscopic pathology|8-1-10-50|10|1093|Neoplasia malignant|Lower respiratory system|n/a|
		
